ATS (Advanced Tissue Sciences) restructures and creates subsidiary for new challenges
This article was originally published in Clinica
Executive Summary
Californian tissue engineering and wound care specialist Advanced Tissue Sciences (ATS) is to realign its existing structure to address new commercial opportunities based around its core technology. The plan is designed to flesh out new strategy aims, which are to move ahead with short and medium-term commercialisation efforts for fibroblast-based products and increase partnership activities with distributors, where necessary. The aim of all this activity is to "bring this company to profitability", says president and CEO Arthur Benvenuto.